1. Home
  2. KRTX

KRTX

Karuna Therapeutics Inc.

Logo Karuna Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

0

Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.

Founded: 2009 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 12.3B IPO Year: 2019
Target Price: $285.71 AVG Volume (30 days): 971.8K
Analyst Decision: Buy Number of Analysts: 17
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -11.73 EPS Growth: N/A
52 Week Low/High: $158.38 - $329.99 Next Earning Date: 05-02-2024
Revenue: $654,000 Revenue Growth: -93.85%
Revenue Growth (this year): 4201.53% Revenue Growth (next year): 828.27%

Share on Social Networks: